Memantine: all 200 studies that test it

Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.

• Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain InjuryStatus unknownNCT05531383Not applicable
• Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's DiseaseStatus unknownNCT05430867Phase 4
• Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug ChallengeActive, not recruitingNCT05418049Phase 2
• The Use of Memantine for Prevention of Alzheimer's DiseaseActive, not recruitingNCT05063851Phase 2
• Memantine for Refractory OCD PatientsStatus unknownNCT05015595Phase 3
• Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD)WithdrawnNCT04966546Early Phase 1
• A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain TumorActive, not recruitingNCT04939597Phase 3
• The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral NeuropathyStatus unknownNCT04737967Phase 2/3
• Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine AddictionStatus unknownNCT04687566Phase 2/3
• Effect of Memantine on Cognitive Impairment in Patients With EpilepsyCompletedNCT04417543Phase 1
• Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System TumorsCompletedNCT04217694Early Phase 1
• Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, MemantineStatus unknownNCT03858270Phase 3
• Memantine for Epileptic EncephalopathyCompletedNCT03779672Phase 4
• Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use DisorderCompletedNCT03729128Phase 1/2
• Memantine and Post-mastectomy Neuropathic PainStatus unknownNCT03686774Phase 2
• Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed ConditionsCompletedNCT03670095Phase 1
• Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social InteractionsTerminatedNCT03553875Phase 3
• Memantine for the Treatment of Cognitive Impairment in Systemic Lupus ErythematosusCompletedNCT03527472Phase 2
• Effect of Memantine on Radiotherapy-related Cognitive ImpairmentStatus unknownNCT03342443Phase 2/3
• A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCDStatus unknownNCT03247218Phase 2
• Memantine Treatment in Alzheimer's Disease PatientsStatus unknownNCT03168997Phase 4
• Memantine in Bipolar Patients With AlcoholismStatus unknownNCT03043001Phase 3
• Combination of Dextromethorphan and Memantine in Treating Bipolar DisorderStatus unknownNCT03039842Phase 3
• Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance SpectroscopyCompletedNCT02811627Early Phase 1
• Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders PatientsStatus unknownNCT02630888Phase 2
• Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients OutcomeCompletedNCT02467556Phase 4
• Treatment of Pendular Nystagmus in OPTCompletedNCT02466191Phase 4
• Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
• Prediction of Cognitive Properties of Memantine for Neurodegenerative DiseasesTerminatedNCT02288000Phase 1
• An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress DisorderCompletedNCT02258828Phase 4
• Effect of Memantine on ERP in Early Schizophrenia and Healthy SubjectsStatus unknownNCT02233556Not applicable
• Impact of Persistent Conductances on Motor Unit Firing in SCIStatus unknownNCT02136823Not applicable
• A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy AdultsCompletedNCT02001584Phase 1
• Memantine add-on for Cognitive and Negative Symptoms of SchizophreniaStatus unknownNCT02001103Phase 3
• The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's DiseaseCompletedNCT01921972Phase 4
• Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's DiseaseStatus unknownNCT01849042Phase 4
• Memantine Monotherapy for Executive Dysfunction and ADHDWithdrawnNCT01844427Not applicable
• Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple SclerosisCompletedNCT01744444Phase 2
• Randomised Controlled Trial of Memantine in FibromyalgiaStatus unknownNCT01653457Phase 3
• Study of NMDA Antagonists and Neuropathic PainCompletedNCT01602185Phase 2
• Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy VolunteersCompletedNCT01461174Phase 1
• A Trial of Memantine as Symptomatic Treatment for Early Huntington DiseaseCompletedNCT01458470Phase 2
• Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation TherapyTerminatedNCT01430351Phase 1
• Treatment Resistant Geriatric Depression in Primary CareCompletedNCT01392287Phase 1
• A Multi-site Double-blind Placebo-controlled Trial of Memantine Versus Placebo in Children With Autism (MEM)CompletedNCT01372449Phase 2
• Investigation of Memantine in the Treatment of Memory, Concentration or Attention ProblemsCompletedNCT01261741Phase 2
• A Study of the Effect of Memantine on Pharmacokinetics, Safety and Tolerability of Single Dose RO5313534 in Healthy Volunteers, and the Effect of RO5313534 on Safety and Tolerability of Steady State MemantineCompletedNCT01196065Phase 1
• Psychopharmacotherapy in Multiple Substances AbuseCompletedNCT01189214Phase 3
• Series Studies of Bipolar Disorder-Valproate add-on MemantineCompletedNCT01188148Phase 2/3
• Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's DiseaseCompletedNCT01108029Phase 4
• Study on Cognitive Disorders of Multiple SclerosisCompletedNCT01074619Phase 3
• Memantine for Post-Operative Pain ControlStatus unknownNCT01041313Phase 4
• Exelon Patch and Combination With Memantine Comparative TrialCompletedNCT01025466Phase 4
• Memantine Therapy in Amyotrophic Lateral SclerosisCompletedNCT01020331Phase 2
• The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?WithdrawnNCT00988663Not applicable
• Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With EpilepsyWithdrawnNCT00986115Not applicable
• The Influence of Glutamate on Memory in HumansCompletedNCT00980408Not applicable
• Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy BodiesCompletedNCT00855686Phase 4
• Memantine and Validation of a New Alzheimer's Disease ScaleCompletedNCT00804271Phase 3
• Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's DiseaseCompletedNCT00800709Phase 4
• Memantine as Adjunctive Therapy for Schizophrenia Negative SymptomsCompletedNCT00757978Phase 4
• Memantine on Aggression and Agitation of Alzheimer's Disease (AD)Status unknownNCT00703430Not applicable
• Memantine and Intensive Speech-Language Therapy in AphasiaCompletedNCT00640198Phase 4
• Memantine Therapy for Multiple SclerosisTerminatedNCT00638833Phase 2
• Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)CompletedNCT00630500Phase 2
• Memantine - Communication StudyCompletedNCT00624026Phase 3
• Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal DementiaCompletedNCT00594737Phase 3
• Memantine Versus Donepezil in Early Stages of Alzheimer's DiseaseCompletedNCT00505167Phase 4
• A Pilot Clinical Trial Of Memantine for Essential TremorCompletedNCT00439699Phase 4
• The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00409721Phase 2
• Memantine for Agitation and Aggression in Severe Alzheimer's DiseaseCompletedNCT00401167Phase 4
• Parkinson's Disease Evaluated by PET and the Effect of MemantineCompletedNCT00375778Not applicable
• Memantine for Agitation in DementiaCompletedNCT00371059Phase 4
• Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.CompletedNCT00368862Phase 4
• Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)CompletedNCT00353665Phase 2/3
• Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)CompletedNCT00334906Phase 4
• An Open-Label Trial of Memantine in the Treatment of Binge Eating DisorderCompletedNCT00330655Phase 4
• Prophylactic Effect of Memantine in Chronic Tension-Type HeadacheCompletedNCT00315666Phase 3
• Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's DiseaseCompletedNCT00305903Phase 4
• Namenda to Prevent Post-Operative DeliriumTerminatedNCT00303433Phase 4
• Trial of Memantine for Cognitive Impairment in Multiple SclerosisCompletedNCT00300716Phase 2/3
• Memantine for Corticosteroid-Induced Mood and Declarative Memory ChangesCompletedNCT00280774Phase 4
• Treatment of Orthostatic IntoleranceActive, not recruitingNCT00262470Phase 1/2
• A Placebo-Controlled Trial of Memantine for Alcohol DependenceCompletedNCT00246415Phase 2
• Memantine and Down's SyndromeStatus unknownNCT00240760Not applicable
• Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor TreatmentCompletedNCT00234637Phase 4
• Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) PatientsCompletedNCT00200538Phase 2
• Memantine and Constraint-Induced Language Therapy in Chronic Poststroke Aphasia:A Randomized Controlled TrialStatus unknownNCT00196703Phase 4
• A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar DegenerationCompletedNCT00187525Phase 4
• Memantine in Systemic Lupus ErythematosusCompletedNCT00181298Not applicable
• Memantine in Patients With Chronic GlaucomaCompletedNCT00168350Phase 3
• Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic SchizophreniaTerminatedNCT00148616Phase 3
• Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute SchizophreniaTerminatedNCT00148590Phase 3
• Memantine in Patients With Chronic GlaucomaCompletedNCT00141882Phase 3
• The Effects of Memantine and Bupropion on Acute, Reinforcing, and Conditioned Effects of Cigarettes - 1CompletedNCT00136747Phase 1
• An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I DisorderCompletedNCT00106405Phase 2
• Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia PatientsCompletedNCT00097942Phase 2
• An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's DiseaseCompletedNCT00097916Phase 3
• Clinical Trial of Memantine for Major DepressionCompletedNCT00040261Phase 3
• A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)CompletedNCT00000867Phase 2

← Memantine overview